{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:29:53Z","timestamp":1791811793396,"version":"4.3.4"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108005"],"award-info":[{"award-number":["81820108005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270551"],"award-info":[{"award-number":["82270551"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900502"],"award-info":[{"award-number":["81900502"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["No. 2020YFA0710803"],"award-info":[{"award-number":["No. 2020YFA0710803"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2017YFA0105704"],"award-info":[{"award-number":["2017YFA0105704"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["No. 2021ZDLSF02-07"],"award-info":[{"award-number":["No. 2021ZDLSF02-07"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2022ZDLSF03-03"],"award-info":[{"award-number":["2022ZDLSF03-03"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00535-023-02008-4","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T13:02:01Z","timestamp":1687957321000},"page":"718-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment"],"prefix":"10.1007","volume":"58","author":[{"given":"Lan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3046-9507","authenticated-orcid":false,"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"2008_CR1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201\u20136.","journal-title":"Nature"},{"key":"2008_CR2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0005-2787(69)90078-1","volume":"190","author":"M Saneyoshi","year":"1969","unstructured":"Saneyoshi M, Harada F, Nishimura S. Isolation and characterization of N6-methyladenosine from Escherichia coli valine transfer RNA. Biochim Biophys Acta. 1969;190:264\u201373.","journal-title":"Biochim Biophys Acta"},{"key":"2008_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0003-9861(68)90553-5","volume":"126","author":"Y Iwanami","year":"1968","unstructured":"Iwanami Y, Brown GM. Methylated bases of ribosomal ribonucleic acid from HeLa cells. Arch Biochem Biophys. 1968;126:8\u201315.","journal-title":"Arch Biochem Biophys"},{"key":"2008_CR4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/cr.2017.31","volume":"27","author":"Y Yang","year":"2017","unstructured":"Yang Y, Fan X, Mao M, et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. 2017;27:626\u201341.","journal-title":"Cell Res"},{"key":"2008_CR5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell. 2012;149:1635\u201346.","journal-title":"Cell"},{"key":"2008_CR6","first-page":"1233","volume":"3","author":"JA Bokar","year":"1997","unstructured":"Bokar JA, Shambaugh ME, Polayes D, et al. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997;3:1233\u201347.","journal-title":"RNA"},{"key":"2008_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93\u20135.","journal-title":"Nat Chem Biol"},{"key":"2008_CR8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63:306\u201317.","journal-title":"Mol Cell"},{"key":"2008_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24:177\u201389.","journal-title":"Cell Res"},{"key":"2008_CR10","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.15252\/embr.201744940","volume":"18","author":"AS Warda","year":"2017","unstructured":"Warda AS, Kretschmer J, Hackert P, et al. Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs. EMBO Rep. 2017;18:2004\u201314.","journal-title":"EMBO Rep"},{"key":"2008_CR11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41589-018-0184-3","volume":"15","author":"H Ma","year":"2019","unstructured":"Ma H, Wang X, Cai J, et al. N(6-)methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation. Nat Chem Biol. 2019;15:88\u201394.","journal-title":"Nat Chem Biol"},{"key":"2008_CR12","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1093\/nar\/gkz619","volume":"47","author":"N van Tran","year":"2019","unstructured":"van Tran N, Ernst FGM, Hawley BR, et al. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucl Acids Res. 2019;47:7719\u201333.","journal-title":"Nucl Acids Res"},{"key":"2008_CR13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s42255-022-00622-9","volume":"4","author":"H Peng","year":"2022","unstructured":"Peng H, Chen B, Wei W, et al. N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nat Metab. 2022;4:1041\u201354.","journal-title":"Nat Metab"},{"key":"2008_CR14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885\u20137.","journal-title":"Nat Chem Biol"},{"key":"2008_CR15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder B, Grozhik AV, Olarerin-George AO, et al. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods. 2015;12:767\u201372.","journal-title":"Nat Methods"},{"issue":"973\u201385","key":"2008_CR16","volume":"71","author":"J Wei","year":"2018","unstructured":"Wei J, Liu F, Lu Z, et al. Differential m(6)A, m(6)Am, and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol Cell. 2018;71(973\u201385): e5.","journal-title":"Mol Cell"},{"key":"2008_CR17","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/ncomms2822","volume":"4","author":"Y Fu","year":"2013","unstructured":"Fu Y, Jia G, Pang X, et al. FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA. Nat Commun. 2013;4:1798.","journal-title":"Nat Commun"},{"key":"2008_CR18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, et al. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020;19:88.","journal-title":"Mol Cancer"},{"key":"2008_CR19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37:270\u201388.","journal-title":"Cancer Cell"},{"key":"2008_CR20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74:640\u201350.","journal-title":"Mol Cell"},{"key":"2008_CR21","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","volume":"48","author":"T Liu","year":"2020","unstructured":"Liu T, Wei Q, Jin J, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucl Acids Res. 2020;48:3816\u201331.","journal-title":"Nucl Acids Res"},{"key":"2008_CR22","doi-asserted-by":"crossref","unstructured":"Zhuang M, Li X, Zhu J, et al. The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression. Nuc Acids Res. 2019;47:4765\u201377.","DOI":"10.1093\/nar\/gkz157"},{"key":"2008_CR23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature15377","volume":"526","author":"J Zhou","year":"2015","unstructured":"Zhou J, Wan J, Gao X, et al. Dynamic m(6)A mRNA methylation directs translational control of heat shock response. Nature. 2015;526:591\u20134.","journal-title":"Nature"},{"key":"2008_CR24","doi-asserted-by":"crossref","first-page":"12626","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du H, Zhao Y, He J, et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun. 2016;7:12626.","journal-title":"Nat Commun"},{"key":"2008_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cr.2017.15","volume":"27","author":"H Shi","year":"2017","unstructured":"Shi H, Wang X, Lu Z, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 2017;27:315\u201328.","journal-title":"Cell Res"},{"key":"2008_CR26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/cr.2017.10","volume":"27","author":"A Li","year":"2017","unstructured":"Li A, Chen YS, Ping XL, et al. Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation. Cell Res. 2017;27:444\u20137.","journal-title":"Cell Res"},{"key":"2008_CR27","doi-asserted-by":"crossref","unstructured":"Roundtree IA, Luo GZ, Zhang Z, et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elife. 2017;6.","DOI":"10.7554\/eLife.31311"},{"key":"2008_CR28","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1038\/s41467-019-13317-9","volume":"10","author":"Y Mao","year":"2019","unstructured":"Mao Y, Dong L, Liu XM, et al. m(6)A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2. Nat Commun. 2019;10:5332.","journal-title":"Nat Commun"},{"key":"2008_CR29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature14234","volume":"518","author":"N Liu","year":"2015","unstructured":"Liu N, Dai Q, Zheng G, et al. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature. 2015;518:560\u20134.","journal-title":"Nature"},{"issue":"70\u201381","key":"2008_CR30","volume":"76","author":"KI Zhou","year":"2019","unstructured":"Zhou KI, Shi H, Lyu R, et al. Regulation of co-transcriptional pre-mRNA splicing by m(6)A through the low-complexity protein hnRNPG. Mol Cell. 2019;76(70\u201381): e9.","journal-title":"Mol Cell"},{"key":"2008_CR31","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarcon","year":"2015","unstructured":"Alarcon CR, Goodarzi H, Lee H, et al. HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell. 2015;162:1299\u2013308.","journal-title":"Cell"},{"key":"2008_CR32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer KD, Patil DP, Zhou J, et al. 5\u2019 UTR m(6)A promotes cap-independent translation. Cell. 2015;163:999\u20131010.","journal-title":"Cell"},{"key":"2008_CR33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"2008_CR34","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C. m(6) A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021;40: e105977.","journal-title":"EMBO J"},{"issue":"Suppl 1","key":"2008_CR35","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis\u2014from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38-53.","journal-title":"J Hepatol"},{"key":"2008_CR36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209\u201318.","journal-title":"J Clin Invest"},{"key":"2008_CR37","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2217\/epi-2019-0365","volume":"12","author":"Z Cui","year":"2020","unstructured":"Cui Z, Huang N, Liu L, et al. Dynamic analysis of m6A methylation spectroscopy during progression and reversal of hepatic fibrosis. Epigenomics. 2020;12:1707\u201323.","journal-title":"Epigenomics"},{"key":"2008_CR38","volume":"9","author":"C Fan","year":"2021","unstructured":"Fan C, Ma Y, Chen S, et al. Comprehensive analysis of the transcriptome-wide m6A methylation modification difference in liver fibrosis mice by high-throughput m6A sequencing. Front Cell Dev Biol. 2021;9: 767051.","journal-title":"Front Cell Dev Biol"},{"key":"2008_CR39","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhao Y, Wang Z, et al. Peroxiredoxin 3 inhibits acetaminophen-induced liver pyroptosis through the regulation of mitochondrial ROS. Front Immunol. 2021;12: 652782.","journal-title":"Front Immunol"},{"key":"2008_CR40","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115758","volume":"432","author":"Y Geng","year":"2021","unstructured":"Geng Y, Wang Y, Sun R, et al. Carnosol alleviates nonalcoholic fatty liver disease by inhibiting mitochondrial dysfunction and apoptosis through targeting of PRDX3. Toxicol Appl Pharmacol. 2021;432: 115758.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2008_CR41","volume":"54","author":"R Sun","year":"2022","unstructured":"Sun R, Tian X, Li Y, et al. The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. Redox Biol. 2022;54: 102378.","journal-title":"Redox Biol"},{"key":"2008_CR42","volume":"922","author":"JJ Yang","year":"2022","unstructured":"Yang JJ, Wang J, Yang Y, et al. ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m(6)A dependent manner. Eur J Pharmacol. 2022;922: 174900.","journal-title":"Eur J Pharmacol"},{"key":"2008_CR43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.freeradbiomed.2022.02.028","volume":"182","author":"M Shen","year":"2022","unstructured":"Shen M, Guo M, Li Y, et al. m(6)A methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells. Free Radic Biol Med. 2022;182:246\u201359.","journal-title":"Free Radic Biol Med"},{"key":"2008_CR44","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102151","volume":"47","author":"M Shen","year":"2021","unstructured":"Shen M, Li Y, Wang Y, et al. N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells. Redox Biol. 2021;47: 102151.","journal-title":"Redox Biol"},{"key":"2008_CR45","volume":"9","author":"T Zhao","year":"2022","unstructured":"Zhao T, Qi J, Liu T, et al. N6-methyladenosine modification participates in the progression of hepatitis B virus-related liver fibrosis by regulating immune cell infiltration. Front Med (Lausanne). 2022;9: 821710.","journal-title":"Front Med (Lausanne)"},{"key":"2008_CR46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41420-021-00756-x","volume":"7","author":"B Shu","year":"2021","unstructured":"Shu B, Zhou YX, Li H, et al. The METTL3\/MALAT1\/PTBP1\/USP8\/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis. Cell Death Discov. 2021;7:368.","journal-title":"Cell Death Discov"},{"key":"2008_CR47","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, Zhang Z, Xiang L, et al. Analysis of N6-methyladenosine methylation modification in fructose-induced non-alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2021;12: 780617.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1816\u201328","key":"2008_CR48","volume":"25","author":"X Zhong","year":"2018","unstructured":"Zhong X, Yu J, Frazier K, et al. Circadian clock regulation of hepatic lipid metabolism by modulation of m(6)A mRNA methylation. Cell Rep. 2018;25(1816\u201328): e4.","journal-title":"Cell Rep"},{"key":"2008_CR49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jcmgh.2021.05.007","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng Y, Dong H, Sun B, et al. METTL3\/METTL14 Transactivation and m(6)A-dependent TGF-beta1 translation in activated kupffer cells. Cell Mol Gastroenterol Hepatol. 2021;12:839\u201356.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2008_CR50","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1002\/jcb.26746","volume":"119","author":"H Kang","year":"2018","unstructured":"Kang H, Zhang Z, Yu L, et al. FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation. J Cell Biochem. 2018;119:5676\u201385.","journal-title":"J Cell Biochem"},{"key":"2008_CR51","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s10620-012-2516-6","volume":"58","author":"J Guo","year":"2013","unstructured":"Guo J, Ren W, Li A, et al. Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease. Dig Dis Sci. 2013;58:1004\u20139.","journal-title":"Dig Dis Sci"},{"key":"2008_CR52","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/15476286.2020.1736868","volume":"17","author":"Y Hu","year":"2020","unstructured":"Hu Y, Feng Y, Zhang L, et al. GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m(6)A on lipogenic mRNAs. RNA Biol. 2020;17:930\u201342.","journal-title":"RNA Biol"},{"key":"2008_CR53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.gpb.2020.06.003","volume":"18","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang Q, Cui G, et al. m(6)A regulates liver metabolic disorders and hepatogenous diabetes. Genom Proteom Bioinform. 2020;18:371\u201383.","journal-title":"Genom Proteom Bioinform"},{"key":"2008_CR54","volume":"37","author":"Y Qin","year":"2021","unstructured":"Qin Y, Li B, Arumugam S, et al. m(6)A mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity. Cell Rep. 2021;37: 109968.","journal-title":"Cell Rep"},{"key":"2008_CR55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.31220","volume":"73","author":"B Zhou","year":"2021","unstructured":"Zhou B, Liu C, Xu L, et al. N(6)-methyladenosine reader protein YT521-B homology domain-containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes. Hepatology. 2021;73:91\u2013103.","journal-title":"Hepatology"},{"key":"2008_CR56","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gutjnl-2020-323153","volume":"71","author":"C Peneau","year":"2022","unstructured":"Peneau C, Imbeaud S, La Bella T, et al. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut. 2022;71:616\u201326.","journal-title":"Gut"},{"key":"2008_CR57","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3748\/wjg.v25.i27.3527","volume":"25","author":"TY Li","year":"2019","unstructured":"Li TY, Yang Y, Zhou G, et al. Immune suppression in chronic hepatitis B infection associated liver disease: a review. World J Gastroenterol. 2019;25:3527\u201337.","journal-title":"World J Gastroenterol"},{"key":"2008_CR58","doi-asserted-by":"crossref","unstructured":"Kim GW, Siddiqui A. Hepatitis B virus X protein recruits methyltransferases to affect cotranscriptional N6-methyladenosine modification of viral\/host RNAs. Proc Natl Acad Sci USA. 2021;118.","DOI":"10.1073\/pnas.2019455118"},{"key":"2008_CR59","volume":"95","author":"GW Kim","year":"2021","unstructured":"Kim GW, Imam H, Siddiqui A. The RNA binding proteins YTHDC1 and FMRP regulate the nuclear export of N(6)-methyladenosine-modified hepatitis B virus transcripts and affect the viral life cycle. J Virol. 2021;95: e0009721.","journal-title":"J Virol"},{"key":"2008_CR60","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1073\/pnas.1808319115","volume":"115","author":"H Imam","year":"2018","unstructured":"Imam H, Khan M, Gokhale NS, et al. N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle. Proc Natl Acad Sci USA. 2018;115:8829\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2008_CR61","doi-asserted-by":"crossref","unstructured":"Kim GW, Moon JS, Siddiqui A. N6-methyladenosine modification of the 5' epsilon structure of the HBV pregenome RNA regulates its encapsidation by the viral core protein. Proc Natl Acad Sci USA. 2022;119.","DOI":"10.1073\/pnas.2120485119"},{"key":"2008_CR62","volume":"96","author":"GW Kim","year":"2022","unstructured":"Kim GW, Siddiqui A. Hepatitis B virus X protein expression is tightly regulated by N6-methyladenosine modification of its mRNA. J Virol. 2022;96: e0165521.","journal-title":"J Virol"},{"key":"2008_CR63","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.31313","volume":"73","author":"GW Kim","year":"2021","unstructured":"Kim GW, Imam H, Khan M, et al. HBV-induced increased N6 methyladenosine modification of PTEN RNA affects innate immunity and contributes to HCC. Hepatology. 2021;73:533\u201347.","journal-title":"Hepatology"},{"key":"2008_CR64","doi-asserted-by":"crossref","first-page":"13123","DOI":"10.1074\/jbc.RA120.014260","volume":"295","author":"GW Kim","year":"2020","unstructured":"Kim GW, Imam H, Khan M, et al. N(6)-methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling. J Biol Chem. 2020;295:13123\u201333.","journal-title":"J Biol Chem"},{"key":"2008_CR65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008338","volume":"16","author":"H Imam","year":"2020","unstructured":"Imam H, Kim GW, Mir SA, et al. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts. PLoS Pathog. 2020;16: e1008338.","journal-title":"PLoS Pathog"},{"key":"2008_CR66","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12885-021-08449-5","volume":"21","author":"S Qu","year":"2021","unstructured":"Qu S, Jin L, Huang H, et al. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis. BMC Cancer. 2021;21:686.","journal-title":"BMC Cancer"},{"key":"2008_CR67","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41374-022-00731-9","volume":"102","author":"L Tao","year":"2022","unstructured":"Tao L, Li D, Mu S, et al. LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma. Lab Invest. 2022;102:494\u2013504.","journal-title":"Lab Invest"},{"key":"2008_CR68","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/iub.2438","volume":"73","author":"X Rao","year":"2021","unstructured":"Rao X, Lai L, Li X, et al. N(6)-methyladenosine modification of circular RNA circ-ARL3 facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305. IUBMB Life. 2021;73:408\u201317.","journal-title":"IUBMB Life"},{"key":"2008_CR69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2008_CR70","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254\u201370.","journal-title":"Hepatology"},{"key":"2008_CR71","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/s41467-019-09865-9","volume":"10","author":"X Lin","year":"2019","unstructured":"Lin X, Chai G, Wu Y, et al. RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail. Nat Commun. 2019;10:2065.","journal-title":"Nat Commun"},{"key":"2008_CR72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10456-020-09744-8","volume":"24","author":"K Qiao","year":"2021","unstructured":"Qiao K, Liu Y, Xu Z, et al. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway. Angiogenesis. 2021;24:83\u201396.","journal-title":"Angiogenesis"},{"key":"2008_CR73","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.7150\/thno.42539","volume":"10","author":"H Xu","year":"2020","unstructured":"Xu H, Wang H, Zhao W, et al. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma. Theranostics. 2020;10:5671\u201386.","journal-title":"Theranostics"},{"key":"2008_CR74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen Y, Peng C, Chen J, et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol Cancer. 2019;18:127.","journal-title":"Mol Cancer"},{"key":"2008_CR75","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb2672","volume":"15","author":"J Chou","year":"2013","unstructured":"Chou J, Lin JH, Brenot A, et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat Cell Biol. 2013;15:201\u201313.","journal-title":"Nat Cell Biol"},{"key":"2008_CR76","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12943-019-1106-z","volume":"18","author":"T Lan","year":"2019","unstructured":"Lan T, Li H, Zhang D, et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol Cancer. 2019;18:186.","journal-title":"Mol Cancer"},{"key":"2008_CR77","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/hep.31222","volume":"72","author":"X Liu","year":"2020","unstructured":"Liu X, Liu J, Xiao W, et al. SIRT1 Regulates N(6)-methyladenosine RNA modification in hepatocarcinogenesis by inducing RANBP2-dependent FTO SUMOylation. Hepatology. 2020;72:2029\u201350.","journal-title":"Hepatology"},{"key":"2008_CR78","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-020-01239-w","volume":"19","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhao Y, Chen J, et al. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1. Mol Cancer. 2020;19:123.","journal-title":"Mol Cancer"},{"key":"2008_CR79","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41388-020-1303-7","volume":"39","author":"C Zhang","year":"2020","unstructured":"Zhang C, Huang S, Zhuang H, et al. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 2020;39:4507\u201318.","journal-title":"Oncogene"},{"key":"2008_CR80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2018.11.006","volume":"442","author":"L Zhong","year":"2019","unstructured":"Zhong L, Liao D, Zhang M, et al. YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma. Cancer Lett. 2019;442:252\u201361.","journal-title":"Cancer Lett"},{"key":"2008_CR81","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbrc.2016.08.059","volume":"478","author":"Y Ma","year":"2016","unstructured":"Ma Y, Han CC, Li Y, et al. Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells by controlling bFGF and PDGF autocrine\/paracrine loops. Biochem Biophys Res Commun. 2016;478:964\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2008_CR82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ccr.2014.06.018","volume":"26","author":"LH Nguyen","year":"2014","unstructured":"Nguyen LH, Robinton DA, Seligson MT, et al. Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell. 2014;26:248\u201361.","journal-title":"Cancer Cell"},{"key":"2008_CR83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","volume":"65","author":"JZ Ma","year":"2017","unstructured":"Ma JZ, Yang F, Zhou CC, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6)-methyladenosine-dependent primary MicroRNA processing. Hepatology. 2017;65:529\u201343.","journal-title":"Hepatology"},{"key":"2008_CR84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","volume":"13","author":"X Zuo","year":"2020","unstructured":"Zuo X, Chen Z, Gao W, et al. M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. J Hematol Oncol. 2020;13:5.","journal-title":"J Hematol Oncol"},{"key":"2008_CR85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s43018-021-00315-4","volume":"3","author":"A Xia","year":"2022","unstructured":"Xia A, Yuan W, Wang Q, et al. The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription. Nat Cancer. 2022;3:203\u201318.","journal-title":"Nat Cancer"},{"key":"2008_CR86","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1007\/s13577-021-00587-z","volume":"34","author":"YT Chen","year":"2021","unstructured":"Chen YT, Xiang D, Zhao XY, et al. Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m(6)A methylation promotes disease progression and sorafenib resistance. Hum Cell. 2021;34:1800\u201311.","journal-title":"Hum Cell"},{"key":"2008_CR87","doi-asserted-by":"crossref","unstructured":"Peng L, Pan B, Zhang X, et al. Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression. Cell Biol Toxicol. 2022.","DOI":"10.1007\/s10565-022-09718-0"},{"key":"2008_CR88","volume":"9","author":"W Liang","year":"2021","unstructured":"Liang W, Wang Y, Zhang Q, et al. M(6)A-mediated upregulation of LINC00106 promotes stemness and metastasis properties of hepatocellular carcinoma via sponging Let7f. Front Cell Dev Biol. 2021;9: 781867.","journal-title":"Front Cell Dev Biol"},{"key":"2008_CR89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s11658-022-00342-8","volume":"27","author":"YZ Dai","year":"2022","unstructured":"Dai YZ, Liu YD, Li J, et al. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6)A-dependent manner. Cell Mol Biol Lett. 2022;27:41.","journal-title":"Cell Mol Biol Lett"},{"key":"2008_CR90","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.omtn.2021.09.001","volume":"26","author":"D Rong","year":"2021","unstructured":"Rong D, Wu F, Lu C, et al. m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Mol Ther Nucl Acids. 2021;26:637\u201348.","journal-title":"Mol Ther Nucl Acids"},{"key":"2008_CR91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12943-022-01575-z","volume":"21","author":"A Du","year":"2022","unstructured":"Du A, Li S, Zhou Y, et al. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer. 2022;21:109.","journal-title":"Mol Cancer"},{"key":"2008_CR92","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.7150\/thno.53227","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H, Lan T, Li H, et al. Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR. Theranostics. 2021;11:1396\u2013411.","journal-title":"Theranostics"},{"key":"2008_CR93","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/0008-5472.CAN-21-1628","volume":"82","author":"Y Chen","year":"2022","unstructured":"Chen Y, Ling Z, Cai X, et al. Activation of YAP1 by N6-methyladenosine-modified circCPSF6 drives malignancy in hepatocellular carcinoma. Cancer Res. 2022;82:599\u2013614.","journal-title":"Cancer Res"},{"key":"2008_CR94","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-022-01537-5","volume":"21","author":"JL Duan","year":"2022","unstructured":"Duan JL, Chen W, Xie JJ, et al. A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Mol Cancer. 2022;21:93.","journal-title":"Mol Cancer"},{"key":"2008_CR95","volume":"9","author":"A Wu","year":"2021","unstructured":"Wu A, Hu Y, Xu Y, et al. Methyltransferase-like 3-mediated m6A methylation of Hsa_circ_0058493 accelerates hepatocellular carcinoma progression by binding to YTH domain-containing protein 1. Front Cell Dev Biol. 2021;9: 762588.","journal-title":"Front Cell Dev Biol"},{"key":"2008_CR96","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-022-01619-4","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, Gu M, Ma J, et al. CircGPR137B\/miR-4739\/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma. Mol Cancer. 2022;21:149.","journal-title":"Mol Cancer"},{"key":"2008_CR97","volume":"11","author":"N Qu","year":"2021","unstructured":"Qu N, Bo X, Li B, et al. Role of N6-methyladenosine (m(6)A) methylation regulators in hepatocellular carcinoma. Front Oncol. 2021;11: 755206.","journal-title":"Front Oncol"},{"key":"2008_CR98","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s13577-021-00608-x","volume":"34","author":"C Bo","year":"2021","unstructured":"Bo C, Li N, He L, et al. Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m(6)A-dependent manner. Hum Cell. 2021;34:1843\u201354.","journal-title":"Hum Cell"},{"key":"2008_CR99","volume":"11","author":"F Chen","year":"2021","unstructured":"Chen F, Li M, Wang L. LncRNA CASC11 promotes hepatocellular carcinoma progression via upregulation of UBE2T in a m(6)A-dependent manner. Front Oncol. 2021;11: 772671.","journal-title":"Front Oncol"},{"key":"2008_CR100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13105-015-0420-1","volume":"71","author":"J Chen","year":"2015","unstructured":"Chen J, Zhou X, Wu W, et al. FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice. J Physiol Biochem. 2015;71:405\u201313.","journal-title":"J Physiol Biochem"},{"key":"2008_CR101","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12906-018-2424-1","volume":"19","author":"Y Dang","year":"2019","unstructured":"Dang Y, Hao S, Zhou W, et al. The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules. BMC Complement Altern Med. 2019;19:8.","journal-title":"BMC Complement Altern Med"},{"key":"2008_CR102","volume":"2013","author":"T Liu","year":"2013","unstructured":"Liu T, Yang LL, Zou L, et al. Chinese medicine formula lingguizhugan decoction improves beta-oxidation and metabolism of fatty acid in high-fat-diet-induced rat model of fatty liver disease. Evid Based Complement Alternat Med. 2013;2013: 429738.","journal-title":"Evid Based Complement Alternat Med"},{"key":"2008_CR103","volume":"127","author":"Y Dang","year":"2020","unstructured":"Dang Y, Xu J, Yang Y, et al. Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine. Biomed Pharmacother. 2020;127: 109976.","journal-title":"Biomed Pharmacother"},{"key":"2008_CR104","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2010.03.027","volume":"53","author":"YW Chen","year":"2010","unstructured":"Chen YW, Liu BW, Zhang YJ, et al. Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver. J Hepatol. 2010;53:528\u201336.","journal-title":"J Hepatol"},{"key":"2008_CR105","volume":"813","author":"A Wei","year":"2022","unstructured":"Wei A, Zhao F, Hao A, et al. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP\/m(6)A\/Ptch1 axis through Hedgehog pathway. Gene. 2022;813: 146125.","journal-title":"Gene"},{"key":"2008_CR106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/lipd.12023","volume":"53","author":"N Lu","year":"2018","unstructured":"Lu N, Li X, Yu J, et al. Curcumin attenuates lipopolysaccharide-induced hepatic lipid metabolism disorder by modification of m(6) A RNA methylation in piglets. Lipids. 2018;53:53\u201363.","journal-title":"Lipids"},{"key":"2008_CR107","doi-asserted-by":"crossref","unstructured":"Peng S, Xiao W, Ju D, et al. Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1. Sci Transl Med. 2019;11.","DOI":"10.1126\/scitranslmed.aau7116"},{"key":"2008_CR108","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1021\/ja3064149","volume":"134","author":"B Chen","year":"2012","unstructured":"Chen B, Ye F, Yu L, et al. Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc. 2012;134:17963\u201371.","journal-title":"J Am Chem Soc"},{"key":"2008_CR109","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1074\/jbc.M115.711895","volume":"291","author":"Q Li","year":"2016","unstructured":"Li Q, Huang Y, Liu X, et al. Rhein inhibits AlkB repair enzymes and sensitizes cells to methylated DNA damage. J Biol Chem. 2016;291:11083\u201393.","journal-title":"J Biol Chem"},{"issue":"90\u2013105","key":"2008_CR110","volume":"172","author":"R Su","year":"2018","unstructured":"Su R, Dong L, Li C, et al. R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling. Cell. 2018;172(90\u2013105): e23.","journal-title":"Cell"},{"issue":"677\u201391","key":"2008_CR111","volume":"35","author":"Y Huang","year":"2019","unstructured":"Huang Y, Su R, Sheng Y, et al. Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell. 2019;35(677\u201391): e10.","journal-title":"Cancer Cell"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-023-02008-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-023-02008-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-023-02008-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T11:07:48Z","timestamp":1690196868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-023-02008-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1007\/s00535-023-02008-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]},"assertion":[{"value":"18 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no relevant conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}